World failed to achieve 2020 mental health target: WHO

New Delhi: The world missed most of the 2020 mental health targets, and has failed to provide people with the mental health services they need, at a time when the Covid-19 pandemic is highlighting a growing need for mental health support, according to a World Health Organisation (WHO) report released on Friday. The Mental Health Atlas report, released ahead of the World Mental Health Day on October 10, includes data from 171 countries. It showed that despite increase in attention given to mental health in recent years, it is yet to result in a scale-up of quality mental services that is aligned with needs.

In 2020, just 51 per cent of WHO’s 194 member states reported that their mental health policy or plan was in line with international and regional human rights instruments, way short of the 80 per cent target. Only 52 per cent of countries met the target relating to mental health promotion and prevention programmes, yet well below the 80 per cent target.

Reduction in the rate of suicide by 10 per cent, was the only target met, but even then, only 35 countries had a stand-alone prevention strategy, policy or plan, said the report released every three years.

“It is extremely concerning that, despite the evident and increasing need for mental health services, which has become even more acute during the Covid-19 pandemic, good intentions are not being met with investment,” WHO Director General, Dr Tedros Adhanom Ghebreyesus, said in a statement.

“We must heed and act on this wake-up call and dramatically accelerate the scale-up of investment in mental health, because there is no health without mental health,” he added.

  • Related Posts

    • Pharma
    • June 11, 2025
    • 18 views
    The idea of Modern Medtech Park in Delhi germinates

    Delhi’s Industry Minister sounded amenable, signals west Delhi as site New Delhi: Modern Medical Device Manufacturing Cluster in Delhi may become a reality in foreseeable future. The Surgical Manufacturers &…

    • Pharma
    • June 11, 2025
    • 58 views
    Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases

    Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure Cadila Pharmaceuticals Limited, one of India’s most respected and innovation-driven pharmaceutical companies, has announced the launch…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Doctors trialling ‘poo pills’ to flush out dangerous superbugs

    Doctors trialling ‘poo pills’ to flush out dangerous superbugs

    The idea of Modern Medtech Park in Delhi germinates

    The idea of Modern Medtech Park in Delhi germinates

    Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases

    Cadila launches beta-blocker Biscado for treatment of cardiovascular diseases

    AMTZ moves to build ‘Device’ to rate Buildings on Accessibility Quotient

    AMTZ moves to build ‘Device’ to rate Buildings on Accessibility Quotient